Golden State Wealth Management LLC Makes New $81,000 Investment in The Clorox Company (NYSE:CLX)

Golden State Wealth Management LLC acquired a new stake in The Clorox Company (NYSE:CLX) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 496 shares of the company’s stock, valued at approximately $81,000.

A number of other institutional investors have also made changes to their positions in the business. Catalyst Capital Advisors LLC acquired a new stake in Clorox in the 3rd quarter valued at $54,000. Los Angeles Capital Management LLC increased its position in shares of Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in Clorox by 43.4% during the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its position in Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6 %

NYSE CLX opened at $148.51 on Monday. The firm has a market capitalization of $18.38 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The business’s 50-day moving average price is $161.06 and its two-hundred day moving average price is $158.88. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the firm earned $2.16 EPS. On average, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.29%. Clorox’s payout ratio is 133.33%.

Analysts Set New Price Targets

CLX has been the subject of several recent analyst reports. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.